Keyword: Catalent

Strategy & Management

Facing Strong Headwinds

14.09.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

News

Catalent Invests More in Gene Therapy Campus

11.09.2020 -

Catalent Gene Therapy, a unit of US-based CDMO Catalent, is spending $130 million on five new Phase 3-through commercial-scale manufacturing suites at its gene therapy...

News

Catalent Adds Viral Filling Line at Bloomington

04.09.2020 -

Catalent Biologics is investing $50 million in an additional high-speed vial filling line at its Bloomington, Indiana, USA, facility to support the growing pipeline of...

News

Catalent in new Vaccine Production Deal with AstraZeneca

27.08.2020 -

Catalent Cell & Gene Therapy, a unit of US-based CDMO Catalent, has signed on to provide drug substance manufacturing to AstraZeneca for the University of Oxford’s...

News

Catalent and Humanigen Expand Cooperation

27.07.2020 -

US biotechs Catalent and Humanigen are extending their standing collaboration on lenzilumab, Humanigen’s proprietary anti-human granulocyte macrophage-colony stimulating...

News

Catalent Supports Moderna on Covid-19 Vaccine

04.07.2020 -

US-based CDMO Catalent has agreed a collaboration with US biotech Moderna for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine...

News

Pfizer to Make Space for Vaccine Production

13.05.2020 -

To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to...

News

Pfizer to Make Space for Vaccine Production

12.05.2020 - To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to be shared...